Jeff Joseph1,2, Benjamin Weppner1,2, Nandor K Pinter2,3,4,5, Mohammad Mahdi Shiraz Bhurwani1,2, Andre Monteiro2,4, Ammad Baig2,4, Jason Davies2,4,6,7, Adnan Siddiqui2,4,7, Ciprian N Ionita1,2,7. 1. Department of Biomedical Engineering, University at Buffalo, Buffalo NY 14228. 2. Canon Stroke and Vascular Research Center, Buffalo, NY 14203. 3. DENT Neurological Institute, Buffalo NY 14203. 4. Department of Neurosurgery, University at Buffalo Jacobs School of Medicine, Buffalo NY 14228. 5. Vrije Universiteit Amsterdam. 6. University Dept. of Biomedical Informatics, University at Buffalo, Buffalo, NY 14214. 7. QAS.AI Incorporated, Buffalo NY 14203.
Abstract
Purpose: To investigate the relation between delayed ischemic stroke and the intracranial atherosclerotic disease (ICAD) hemodynamics as determined by Non-invasive Optimal Vessel Analysis (NOVA) MRI measurements. Materials and Methods: Thirty-three patients with ICAD were enrolled in this study. All patients underwent clinically indicated angioplasty followed by 2-dimensional phase contrast MR (2D PCMR) performed on a 3.0 Tesla MRI scanner using either a 16-channel neurovascular coil or 32-channel head coil. The volumetric flow rate measurements were calculated from 2D PCMR with Non-invasive Optimal Vessel Analysis (NOVA) software (VasSol, Chicago, IL, USA). Flow rate measurements were obtained in 20 major arteries distal, proximal and within the Circle of Willis. Patients were followed up for six month, and ischemia reoccurrence and location were recorded. Receiver operating characteristic (ROC) analysis was performed using flow rates measurements in the ipsilateral side of the ischemic event occurrence. Results: Complete set of measurements was achieved in n=34. Left and right hemisphere ischemia recurrence was observed in seven and three cases respectively. Best predictor of ischemic event reoccurrence was flow rate in the middle cerebral artery with area under the ROC of 0.821±0.109. Conclusions: This is an effectiveness study to determine whether blood flow measurements in the intracranial vasculature may be predictive of future ischemic events. Our results demonstrated significant correlation between the blood flow measurements using 2D PCMR processed with the NOVA software and the reoccurrence of ischemia. These results support further investigation for using this method for risk stratification of ICAD patients.
Purpose: To investigate the relation between delayed ischemic stroke and the intracranial atherosclerotic disease (ICAD) hemodynamics as determined by Non-invasive Optimal Vessel Analysis (NOVA) MRI measurements. Materials and Methods: Thirty-three patients with ICAD were enrolled in this study. All patients underwent clinically indicated angioplasty followed by 2-dimensional phase contrast MR (2D PCMR) performed on a 3.0 Tesla MRI scanner using either a 16-channel neurovascular coil or 32-channel head coil. The volumetric flow rate measurements were calculated from 2D PCMR with Non-invasive Optimal Vessel Analysis (NOVA) software (VasSol, Chicago, IL, USA). Flow rate measurements were obtained in 20 major arteries distal, proximal and within the Circle of Willis. Patients were followed up for six month, and ischemia reoccurrence and location were recorded. Receiver operating characteristic (ROC) analysis was performed using flow rates measurements in the ipsilateral side of the ischemic event occurrence. Results: Complete set of measurements was achieved in n=34. Left and right hemisphere ischemia recurrence was observed in seven and three cases respectively. Best predictor of ischemic event reoccurrence was flow rate in the middle cerebral artery with area under the ROC of 0.821±0.109. Conclusions: This is an effectiveness study to determine whether blood flow measurements in the intracranial vasculature may be predictive of future ischemic events. Our results demonstrated significant correlation between the blood flow measurements using 2D PCMR processed with the NOVA software and the reoccurrence of ischemia. These results support further investigation for using this method for risk stratification of ICAD patients.
Authors: Scott E Kasner; Marc I Chimowitz; Michael J Lynn; Harriet Howlett-Smith; Barney J Stern; Vicki S Hertzberg; Michael R Frankel; Steven R Levine; Seemant Chaturvedi; Curtis G Benesch; Cathy A Sila; Tudor G Jovin; Jose G Romano; Harry J Cloft Journal: Circulation Date: 2006-01-23 Impact factor: 29.690
Authors: Sepideh Amin-Hanjani; Xinjian Du; Dilip K Pandey; Keith R Thulborn; Fady T Charbel Journal: J Cereb Blood Flow Metab Date: 2014-11-12 Impact factor: 6.200
Authors: Mario Zanaty; James D Rossen; Jorge A Roa; Daichi Nakagawa; Joseph S Hudson; Sami Al Kasab; Kaustubh Limaye; Khaled Asi; Sudeepta Dandapat; Pascal Jabbour; Edgar A Samaniego; David M Hasan Journal: Oper Neurosurg (Hagerstown) Date: 2020-06-01 Impact factor: 2.703
Authors: Alexander R Podgorsak; Kelsey N Sommer; Abhinay Reddy; Vijay Iyer; Michael F Wilson; Frank J Rybicki; Dimitrios Mitsouras; Umesh Sharma; Shinchiro Fujimoto; Kanako K Kumamaru; Erin Angel; Ciprian N Ionita Journal: Med Phys Date: 2020-07-13 Impact factor: 4.071
Authors: Ryan A Rava; Maxim Mokin; Kenneth V Snyder; Muhammad Waqas; Adnan H Siddiqui; Jason M Davies; Elad I Levy; Ciprian N Ionita Journal: J Med Imaging (Bellingham) Date: 2020-02-11
Authors: Pim A L Tonino; Bernard De Bruyne; Nico H J Pijls; Uwe Siebert; Fumiaki Ikeno; Marcel van' t Veer; Volker Klauss; Ganesh Manoharan; Thomas Engstrøm; Keith G Oldroyd; Peter N Ver Lee; Philip A MacCarthy; William F Fearon Journal: N Engl J Med Date: 2009-01-15 Impact factor: 91.245
Authors: Mohammad Mahdi Shiraz Bhurwani; Kenneth V Snyder; Muhammad Waqas; Maxim Mokin; Ryan A Rava; Alexander R Podgorsak; Felix Chin; Jason M Davies; Elad I Levy; Adnan H Siddiqui; Ciprian N Ionita Journal: Neuroradiology Date: 2021-01-07 Impact factor: 2.995
Authors: Kyle A Williams; Alexander R Podgorsak; Mohammad Mahdi Shiraz Bhurwani; Ryan A Rava; Kelsey N Sommer; Ciprian N Ionita Journal: Proc SPIE Int Soc Opt Eng Date: 2021-02-15